Atomo is still very new on the market and sp is stable at 180% already.
Some ipo investors will like to take profit and waiting for re-entry at lower level. As they can see the potential of Atomo, but think the limitations for the sp to increase rapidly for now, due to manufacturing capacity.
This give good opportunity for experienced trader, as the risk is relatively low.
Ann: Atomo & Access Bio sign deal for rapid antigen test, page-34
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
